Skip to main content

Table 4 Diagnosis efficiency of circRNAs for breast cancer

From: circRNAs and their relationship with breast cancer: a review

CircRNA

Expression in BC

Subtype of BC

Sample

AUC

Sensitivity

Specificity

Cut-off

Number of cases

Ref.

circACTN4

↑

non-TNBC

Tissue

0.719

0.7

0.7

12.77

80

[45]

hsa_circ_0001785

↑

–

Plasma

0.771

0.786

0.756

–

20

[43]

0.784

0.764

0.699

0.981

57

circSEPT9

↑

TNBC

Tissue

0.711

0.633

0.75

1.971

60

[42]

hsa_circ_103110

↑

IDC

Tissue

0.63

0.63

0.63

8.97

51

[79]

hsa_circ_104689

0.61

0.57

0.55

7.67

hsa_circ_104821

0.60

0.57

0.57

6.04

hsa_circ_006054

↓

0.71

0.65

0.69

14.84

hsa_circ_100219

0.78

0.69

0.71

8.95

hsa_circ_406697

0.64

0.63

0.63

14.24

hsa_circ_0001073

↓

–

Tissue

0.9898

0.9242

0.9737

6.68

132

[78]

circVRK1

↓

–

Tissue

0.72

0.617

0.791

0.425

350

[80]

  1. IDC invasive ductal carcinoma